Top

Published in:

01-11-2013

Viral myocarditis: from experimental models to molecular diagnosis in patients

Authors: Sabine Pankuweit, Karin Klingel

Published in: Heart Failure Reviews | Issue 6/2013

Abstract

Cardiotropic viruses have been implicated as major pathogenetic agents in acute and chronic forms of myocarditis. By the introduction of molecular tools, such as (RT-) polymerase chain reaction ((RT-) PCR) and in situ hybridization in the diagnosis of inflammatory heart disease, genomes of various RNA and DNA viruses comprising enteroviruses, adenoviruses, parvovirus B19 (B19V) and herpesviruses (EBV, HHV6, HCMV) were detected in endomyocardial biopsies of patients with myocarditis and dilated cardiomyopathy. Meanwhile, it is known that the outcome of a virus infection in the heart resulting in myocarditis is determined by genetic host factors as well as by the viral pathogenicity which considerably varies in the different virus infections. A considerable portion of our knowledge about the etiopathogenetic mechanisms in viral heart disease is derived from animal studies. Whereas the evolvement of cardiac inflammation in enterovirus infections is guided by viral cytotoxicity and virus persistence, in herpesvirus infections, the pathophysiology is rather determined by primary immune-mediated pathogenicity. By investigation of immunocompetent and gene-targeted mice, valuable new insights into host and virus factors relevant for the control of cardiac viral infection and inflammation were gained which are reviewed in this paper.

Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970PubMed

Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648PubMed

Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS (2009) Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 84:1001–1009PubMed

Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362:1248–1249PubMed

Ruppert V, Meyer T, Balbach A, Richter A, Müller HH, Maisch B, Pankuweit S (2011) German heart failure network. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy. J Med Virol 83:1818–1825PubMed

Gdynia G, Schnitzler P, Brunner E, Kandolf R, Bläker H, Daum E, Schnabel P, Schirmacher P, Roth W (2011) Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis. Virchows Arch 458:371–376PubMed

Barbaro G (2005) HIV-associated myocarditis. Heart Fail Clin 1:439–448 (Review)PubMed

Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol Mech Dis 3:127–155 (Review)

Kandolf R, Klingel K, Mertsching H, Canu A, Hohenadl C, Zell R, Reimann BY, Heim A, McManus BM, Foulis AK et al (1991) Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur Heart J 12(Suppl D):49–55 (Review)PubMed

10.

Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227–1237PubMed

11.

McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, Kandolf R (1993) Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68:159–169PubMed

12.

Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated Cardiomyopathy. J Clin Invest 113:1419–1429PubMed

13.

Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41(1):35–45 (Review)PubMed

14.

Ogata M, Satou T, Kawano R, Takakura S, Goto K, Ikewaki J, Kohno K, Ikebe T, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota J (2010) Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transpl 45:129–136

15.

Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89:314–318PubMed

16.

Shi Y, Chen C, Lisewski U, Wrackmeyer U, Radke M, Westermann D, Sauter M, Tschöpe C, Poller W, Klingel K, Gotthardt M (2009) Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol 53:1219–1226PubMed

17.

Herzum M, Ruppert V, Küytz B, Jomaa H, Nakamura I, Maisch B (1994) Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol 26:907–913PubMed

18.

Chow LH, Beisel KW, McManus BM (1992) Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 66:24–31PubMed

19.

Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453PubMed

20.

Badorff C, Lee GH, Lamphear BJ et al (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326PubMed

21.

Luo H, Zhang J, Cheung C, Suarez A, McManus BM, Yang D (2003) Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol 163:381–385PubMed

22.

Esfandiarei M, Suarez A, Amaral A, Si X, Rahmani M, Dedhar S, McManus BM (2006) Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury. Circ Res 99:354–361PubMed

23.

Wong J, Zhang J, Si X, Gao G, Mao I, McManus BM, Luo H (2008) Autophagosome supports coxsackievirus B3 replication in host cells. J Virol 82:9143–9153PubMed

24.

Wessely R, Klingel K, Knowlton KU, Kandolf R (2001) Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756–761PubMed

25.

Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540–3543PubMed

26.

Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, Kandolf R, Stevanović S, Klingel K (2008) Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82:8149–8160PubMed

27.

Riad A, Westermann D, Escher F, Becher PM, Savvatis K, Lettau O, Heimesaat MM, Bereswill S, Volk HD, Schultheiss HP, Tschöpe C (2010) Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. Am J Physiol Heart Circ Physiol 298(6):H2024–H2031PubMed

28.

Klingel K, Schnorr JJ, Sauter M, Szalay G, Kandolf R (2003) beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol 162:1709–1720PubMed

29.

Opavsky MA, Penninger J, Aitken K, Wen WH, Dawood F, Mak T, Liu P (1999) Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ Res 85:551–558PubMed

30.

Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155:1205–1215PubMed

31.

Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, Fairweather D (2009) Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun 23:649–657PubMed

32.

Szalay G, Sauter M, Hald J, Weinzierl A, Kandolf R, Klingel K (2006) Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 169:2085–2093PubMed

33.

Li K, Xu W, Guo Q, Jiang Z, Wang P, Yue Y, Xiong S (2009) Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 105:353–364PubMed

34.

Cheung C, Luo H, Yanagawa B, Leong HS, Samarasekera D, Lai JC, Suarez A, Zhang J, McManus BM (2006) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis. Cardiovasc Pathol 15:63–74PubMed

35.

Cheung C, Marchant D, Walker EK, Luo Z, Zhang J, Yanagawa B, Rahmani M, Cox J, Overall C, Senior RM, Luo H, McManus BM (2008) Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 117:1574–1582PubMed

36.

Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, Vanhoutte D, Gao F, Torpai R, Baker AH, Padalko E, Neyts J, Schultheiss HP, Van de Werf F, Carmeliet P, Pinto YM (2006) Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 114:565–573PubMed

37.

Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, Klingel K (2009) Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 104:851–859PubMed

38.

Lang C, Sauter M, Szalay G, Racchi G, Grassi G, Rainaldi G, Mercatanti A, Lang F, Kandolf R, Klingel K (2008) Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) 86:49–60

39.

Rother M, Krohn S, Kania G, Vanhoutte D, Eisenreich A, Wang X, Westermann D, Savvatis K, Dannemann N, Skurk C, Hilfiker-Kleiner D, Cathomen T, Fechner H, Rauch U, Schultheiss HP, Heymans S, Eriksson U, Scheibenbogen C, Poller W (2010) Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation 122:2688–2698PubMed

40.

Cunningham MW (2004) T cell mimicry in inflammatory heart disease. Mol Immunol 40:1121–1127PubMed

41.

Li Y, Heuser JS, Cunningham LC et al (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177:8234–8240PubMed

42.

Fousteri G, Dave A, Morin B, Omid S, Croft M, von Herrath MG (2011) Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 36:210–220PubMed

43.

Masek-Hammerman K, Miller AD, Lin KC, Mackey J, Weissenböck H, Gierbolini L, Burgos A, Perez H, Mansfield KG. (2011) Epizootic myocarditis associated with encephalomyocarditis virus in a group of rhesus macaques (Macacamulatta). Vet Pathol 28 [Epub ahead of print]

44.

Oberste MS, Gotuzzo E, Blair P, Nix WA, Ksiazek TG, Comer JA, Rollin P, Goldsmith CS, Olson J, Kochel TJ (2009) Human febrile illness caused by encephalomyocarditis virus infection, Peru. Emerg Infect Dis 15:640–646PubMed

45.

Hardarson HS, Baker JS, Yang Z, Purevjav E, Huang CH, Alexopoulou L, Li N, Flavell RA, Bowles NE, Vallejo JG (2007) Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ Physiol 292:H251–H258PubMed

46.

Yamada T, Matsumori A, Sasayama S (1994) Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89:846–851PubMed

47.

Tanaka T, Kanda T, McManus BM, Kanai H, Akiyama H, Sekiguchi K, Yokoyama T, Kurabayashi M (2001) Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol 33:1627–1635PubMed

48.

Higuchi H, Hara M, Yamamoto K, Miyamoto T, Kinoshita M, Yamada T, Uchiyama K, Matsumori A (2008) Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 118:363–372PubMed

49.

Huang CH, Vallejo JG, Kollias G, Mann DL (2009) Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol 104:228–237PubMed

50.

Takahashi T, Zhu SJ, Sumino H, Saegusa S, Nakahashi T, Iwai K, Morimoto S, Kanda T (2005) Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis. Life Sci 78:195–204PubMed

51.

Matsumori A (2007) Treatment options in myocarditis: what we know from experimental data and how it translates to clinical trials. Herz 32:452–456 (Review)PubMed

52.

Sherry B, Li XY, Tyler KL, Cullen JM, Virgin HW 4th (1993) Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol 67:6119–6124PubMed

53.

Sherry B, Baty CJ, Blum MA (1996) Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J Virol 70:6709–6715PubMed

54.

Sherry B, Torres J, Blum MA (1998) Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol 72:1314–1323PubMed

55.

Virgin HW, Dermody TS, Tyler KL (1998) Cellular and humoral immunity to reovirus infection. Curr Top Microbiol Immunol 233:147–161 (Review)PubMed

56.

Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB (2004) Does Toll-like receptor 3 play a biological role in virus infections? Virology 322:231–238PubMed

57.

Holm GH, Zurney J, Tumilasci V, Leveille S, Danthi P, Hiscott J, Sherry B, Dermody TS (2007) Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J Biol Chem 282:21953–21961PubMed

58.

O’Donnell SM, Holm GH, Pierce JM, Tian B, Watson MJ, Chari RS, Ballard DW, Brasier AR, Dermody TS (2006) Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol 80:1077–1086PubMed

59.

Holm GH, Pruijssers AJ, Li L, Danthi P, Sherry B, Dermody TS (2010) Interferon regulatory factor 3 attenuates reovirus myocarditis and contributes to viral clearance. J Virol 84:6900–6908PubMed

60.

Li L, Sevinsky JR, Rowland MD, Bundy JL, Stephenson JL, Sherry B (2010) Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes. J Proteome Res 9:2460–2471PubMed

61.

Miyamoto SD, Brown RD, Robinson BA, Tyler KL, Long CS, Debiasi RL (2009) Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype. J Card Fail 15:529–539PubMed

62.

DeBiasi RL, Robinson BA, Leser JS, Brown RD, Long CS, Clarke P (2010) Critical role for death-receptor mediated apoptotic signaling in viral myocarditis. J Card Fail 16:901–910PubMed

63.

Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472PubMed

64.

Blailock ZR, Rabin ER, Melnick JL (1968) Adenovirus myocarditis in mice. An electron microscopic study. Exp Mol Pathol 9:84–96PubMed

65.

Kajon AE, Brown CC, Spindler KR (1998) Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J Virol 72:1219–1223PubMed

66.

Guida JD, Fejer G, Pirofski LA, Brosnan CF, Horwitz MS (1995) Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol 69:7674–7681PubMed

67.

Ashley SL, Welton AR, Harwood KM, Van Rooijen N, Spindler KR (2009) Mouse adenovirus type 1 infection of macrophages. Virology 390:307–314PubMed

68.

Nie X, Zhang G, Xu D, Sun X, Li Z, Li X, Zhang X, He F, Li Y (2010) The VP1-unique region of parvovirus B19 induces myocardial injury in mice. Scand J Infect Dis 42:121–128PubMed

69.

Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC (2011) Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 48:1518–1524PubMed

70.

Hoelzer K, Parrish CR (2010) The emergence of parvoviruses of carnivores. Vet Res 41:39PubMed

71.

Meurs KM, Fox PR, Magnon AL, Liu S, Towbin JA (2000) Molecular screening by polymerase chain reaction detects panleukopenia virus DNA in formalin-fixed hearts from cats with idiopathic cardiomyopathy and myocarditis. Cardiovasc Pathol 9:119–126PubMed

72.

Agungpriyono DR, Uchida K, Tabaru H, Yamaguchi R, Tateyama S (1999) Subacute massive necrotizing myocarditis by canine parvovirus type 2 infection with diffuse leukoencephalomalacia in a puppy. Vet Pathol 36:77–80PubMed

73.

Kawai C (1999) From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99:1091–1100 (Review)PubMed

74.

Häusler M, Sellhaus B, Scheithauer S, Gaida B, Kuropka S, Siepmann K, Panek A, Berg W, Teubner A, Ritter K, Kleines M (2007) Myocarditis in newborn wild-type BALB/c mice infected with the murine gamma herpesvirus MHV-68. Cardiovasc Res 76:323–330PubMed

75.

Lenzo JC, Fairweather D, Cull V, Shellam GR, James Lawson CM (2002) Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. J Mol Cell Cardiol 34:629–640PubMed

76.

Ritter JT, Tang-Feldman YJ, Lochhead GR, Estrada M, Lochhead S, Yu C, Ashton-Sager A, Tuteja D, Leutenegger C, Pomeroy C (2010) In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis. Cardiovasc Pathol 19:83–93PubMed

77.

Cull VS, Bartlett EJ, James CM (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology 106:428–437PubMed

78.

Mamas MA, Fraser D, Neyses L (2008) Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130:304–309PubMed

79.

Bratincsák A, El-Said HG, Bradley JS, Shayan K, Grossfeld PD, Cannavino CR (2010) Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 55:928–929PubMed

80.

Pan HY, Yamada H, Chida J, Wang S, Yano M, Yao M, Zhu J, Kido H (2011) Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis. Cardiovasc Res 89:595–603PubMed

81.

Woo GH, Kim HY, Bae YC, Jean YH, Bak EJ, Kim MJ, Hwang EK, Joo YS (2011) Comparative histopathological characteristics of highly pathogenic avian influenza (HPAI) in chickens and domestic ducks in 2008 Korea. Histol Histopathol 26:167–175PubMed

82.

Gabriel G, Klingel K, Planz O, Bier K, Herwig A, Sauter M, Klenk HD (2009) Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus. Am J Pathol 175:1178–1186PubMed

83.

Gabriel G, Klingel K, Otte A, Thiele S, Hudjetz B, Arman-Kalcek G, Sauter M, Shmidt T, Rother F, Baumgarte S, Keiner B, Hartmann E, Bader M, Brownlee GG, Fodor E, Klenk HD (2011) Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun 2:156PubMed

84.

Durando MM, Birks EK, Hussey SB, Lunn DP (2011) Cardiac troponin I concentrations in ponies challenged with equine influenza virus. J Vet Intern Med 25:339–344PubMed

85.

Haugland O, Mikalsen AB, Nilsen P, Lindmo K, Thu BJ, Eliassen TM, Roos N, Rode M, Evensen O (2011) Cardiomyopathy syndrome of atlantic salmon (Salmo salar L.) is caused by a double-stranded RNA virus of the Totiviridae family. J Virol 85:5275–5286PubMed

86.

Fiedler A (1900) Über akute interstitielle Myokarditis. Zentralbl f Med 21:212–213 (Cited by Scott RW, Saphir O (1929–30) Acute isolated myocarditis. Am Heart J 5:129–141.)

87.

Woodruff JF (1980) Viral Myocarditis. Am J Pathol 101:428–479

88.

Sainani GS, Dekate MP, Rao CP (1975) Heart disease caused by Coxsackie virus B infection. Br Heart J 37:819–823PubMed

89.

Gordon RB, Lennette EH, Sandrock RS (1959) The varied clinical manifestations of Coxsackie virus infections. Arch Int Med 103:63–75

90.

Null FC, Castle CH (1959) Adult pericarditis and myocarditis due to coxsackie virus, group B, type 5. N Engl J Med 26i:937–942

91.

Smith WG (1970) Coxsackie B myocarditis in adults. Am Heart J 80:34–46PubMed

92.

Bell EJ, Grist NR (1970) Further studies of enterovirus infections in cardiac disease and pleurodynia. Scan J Infect Dis 2:1–6

93.

Lerner AM, Wilson FM (1973) Virus myocardiomyopathy. Prog Med Virol 15:63–91PubMed

94.

Medearis DN Jr (1957) Cytomegalic inclusion disease: an analysis of the clinical features based on the literature and 6 additional cases. Pediatrics 19:467–480PubMed

95.

Lenette DA, Specter S, Thompson KD (eds) (1979) Diagnosis of viral infections: The role of clinical laboratory. University Park Press, Baltimore

96.

Grist NR, Reid D (1993) Epidemiology of viral infections of the heart. In: Banatvala JE (ed) Viral infections of the heart. Hodder and Stoughton, London, pp 23–31

97.

Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, Kandolf R, Böhm M, Kindermann I (2011) Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 32:897–903PubMed

98.

Sakakibara S, Konno S (1962) Endomyocardial biopsy. Jpn Heart J 3:537–543PubMed

99.

Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Ehrlich HA, Arnheim N (1985) Enzymatic amplification of β3-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354PubMed

100.

Pankuweit S, Portig I, Eckhardt H, Crombach M, Hufnagel G, Maisch B (2000) Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 25(3):221–226PubMed

101.

Jackson DP, Lewis FA, Taylor GR, Boylston AW, Quirke P (1990) Tissue extraction of DNA and RNA and analysis by polymerase chain reaction. J Clin Pathol 43:499–504PubMed

102.

Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMed

103.

Maniatis T, Fritsch EF, Sambrook J (1992) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor

104.

Rotbart HA (1990) Enzymatic RNA amplification of enteroviruses. J Clin Microbiol 28:438–442PubMed

105.

Martin AB, Webber S, Fricker J, Jaffe R et al (1994) Acute myocarditis: rapid diagnosis in children. Circulation 90:330–339PubMed

106.

Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84:6272–6276PubMed

107.

Klingel K, Stephan S, Sauter M, Zell R et al (1996) Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune target cells. J Virol 70:8888–8895PubMed

108.

Klump WM, Bergmann I, Müller BC, Ameis D, Kandolf R (1990) Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J Virol 64:1573–1583PubMed

109.

Archard L, Khan M, Soteriou BA et al (1997) Characterisation of coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578–584

110.

Chapman NM, Tracy S, Gauntt CJ, Fortmüller U (1990) Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridisation. J Clin Microbiol 28:843–850PubMed

111.

Grasso M, Arbustini E, Silini E et al (1992) Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 69:658–664PubMed

112.

Tracy S, Chapman NM, McManus BM et al (1990) A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22:403–414PubMed

113.

Schowengerdt K, Ni J, Denfield S et al (1997) Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection. Diagnosis using the polymerase chain reaction. Circulation 96:3549–3554PubMed

114.

Piiparinen H, Vaheri A (1991) Genotyping of herpes simplex viruses by polymerase chain reaction. Arch Virol 119:541–548

115.

Weiss SM, Roblin PM, Gaydos CA et al (1996) Failure to detect chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173:957–962PubMed

116.

Goodman JL, Jurkovic P, Kramber JM, Johnson RC (1991) Molecular detection of persistent borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immunol 59:269–278

117.

Stanek G, Klein J, Bitnner R, Glogar D (1990) Isolation of borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322:249–252PubMed

118.

Nakhleh RE, Copenhaver CM, Werdin K (1991) Lack of evidence for involvment of Epstein-Barr virus in the development of ‘Quilty’ lesion of transplanted hearts: an in situ hybridization study. J Heart Lung Transpl 10:504–507

119.

Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R (2004) Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 193(2–3):101–107

120.

Kandolf R, Hofschneider PH (1985) Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 82:4818–4822PubMed

121.

Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M (2002) Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 67:275–281PubMed

122.

Harder TC, Hufnagel M, Zahn K, Beutel K, Schmitt H-J, Ullmann U et al (2001) New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections. J Clin Microbiol 39:4413–4419PubMed

123.

Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M (2001) A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92:183–191PubMed

124.

Gruber F, Falkner FG, Dorner F, Hammerle T (2001) Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection. Appl Environ Microbiol 67:2837–2839PubMed

125.

Servant A, Laperche S, Lallemand F, Marinho V, De Maur G, Meritet JF, Garbarg-Chenon A (2002) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76:9124–9134PubMed

126.

Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K (2002) A new parvovirus genotype persistent in human skin. Virology 302:224–228PubMed

127.

Nguyen QT, WongS HeegaardED, Brown KE (2002) Identification and characterization of a second novel human erythrovirus variant A6. Virology 301:374–380PubMed

128.

Heegaard ED, Brown KE (2002) Human parvovirus B 19. Clin Microbiol Rev 15:485–505PubMed

129.

Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S (2005) Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75(1):161–169PubMed

130.

Yajima T, Knowlton KU (2009) Viral myocarditis: from the perspective of the virus. Circulation 119:2615–2624PubMed

131.

Bowles NE, Rose ML, Taylor P et al (1989) End-stage dilated cardiomyopathy persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:1128–1136PubMed

132.

Tracy S, Wiegand V, McManus B et al (1990) Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. JACC 15:1688–1694PubMed

133.

Jin O, Sole M, Butany JW et al (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8–16PubMed

134.

Weiss L, Mohaved L, Billingham ME, Cleary ML (1991) Detection of coxsackie B3 RNA in myocardial tissues by polymerase chain reaction. Am J Pathol 138:497–503PubMed

135.

Kandolf R, Klingel K, Zell R et al (1993) Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 35:140–150PubMed

136.

Petitjan J, Kopecka H, Freymuth F et al (1992) Detection of enteroviruses in endomyocardial biopsy by molecular approach. J Med Virol 37:76–82

137.

Pauschinger M, Dörner G, Meissner G et al (1994) Enteroviral RNA detection by polymerase chain reaction (PCR) in cardiac muscle biopsies of patients with myocarditis or dilated cardiomyopathy. J Am Coll Cardiol 2:880–884

138.

Bowles N, Towbin J (1996) Viral heart muscle disease in children. Newslett Sci Counc Cardiomyopathies 11:4–5

139.

Talwar KK, Thatai D, Kannath P et al (1996) Enteroviral detection by polymerase chain reaction technique in endomyocardial biopsy specimen: an initial study. Indian Heart J 48:479–480

140.

Maisch B, Schönian U, Hufnagel G, Pankuweit S (1997) Enteroviral persistence in myocarditis and dilated cardiomyopathy. Eur Heart J 18:593

141.

Pauschinger M, Phan MD, Dörner A et al (1997) Detection of enteroviral RNA replicative intermediates in endomyocardial biopsies: indication of viral replication in the human heart. Eur Heart J 18:594A

142.

Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic left ventricular dysfunction. Circulation 111:887–893PubMed

143.

Pankuweit S, Ruppert V, Eckhardt H, Strache D, Maisch B (2005) Pathophysiology and etiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B 19. J Vet Med B Infect Dis Vet Public Health 52(7–8):344–347PubMed

144.

Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15):1581–1590PubMed

145.

Kandolf R, Bültmann B, Klingel K, Bock CT (2008) Molecular mechanisms and consequences of cardiac viral infections. Pathologe 29(Suppl 2):112–117PubMed

146.

Pauschinger M, Dörner A, Kühl U et al (1999) Enteroviral replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895PubMed

147.

Chapman M, Kim KS (2008) Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 323:275–292PubMed

148.

Kytö V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, Saraste A, Voipio-Pulkki LM (2005) Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis 40(5):683–688PubMed

149.

Maisch B, Schönian U, Crombach M et al (1993) Cytomegalovirus associated inflammatory heart muscle disease. Scan J Infect Dis suppl 88:135–148

150.

Schönian U, Crombach M, Maisch B (1993) Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. Clin Immun Immunpathol 68:229–233

151.

Towbin JA (1996) Diagnosis and management of myocarditis in children. Newsletter of the Scientific Council on Cardiomyopathies 11:8

152.

Maisch B, Pausch R, Hufnagel G, Schönian U (1997) The neglected role of DNA viruses in chronic myocarditis and dilated cardiomyopathy. Eur Heart J 18:515

153.

Bergelson JM, Cunningham JA, Droguett G et al (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323PubMed

154.

Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94:3352–3356PubMed

155.

Hufnagel G, Busse C, Ische B, Maisch B (1997) Detection of adenoviral DNA in endomyocardial biopsies of adult patients with myocarditis and dilated cardiomyopathy. Eur Heart J 18:515

156.

Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348–1354PubMed

157.

Rohayem J, Dinger J, Fischer R et al (2001) Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39:4585–4587PubMed

158.

Heegaard ED, Eiskjaer H, Baandrup U et al (1998) Case report: parvovirus B19 infection associated with myocarditis following adult cardiac transplantation. Scand J Infect Dis 30:607–610PubMed

159.

Chia JKS (1996) Myopericarditis due to parvovirus B19 in an adult. Clin Infect Dis 23:200–201PubMed

160.

Schwarz TF, Wiersbitzky S, Pambor M (1994) Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol 43:171–174PubMed

161.

Gabriel SE, Espy M, Erdman DD et al (1999) The role of parvovirus B19 in the pathogenesis of giant cell arteritis. Arthritis Rheum 42:1255–1258PubMed

162.

Nigro G, Bastianon V, Colloridi V et al (2000) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 31:65–69PubMed

163.

Sokal EM, Melchior M, Cornu C et al (1998) Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 352:1739–1741PubMed

164.

Enders M, Klingel K, Weidner A, Baisch C, Kandolf R, Schalasta G, Enders G (2010) Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol 49:163–168PubMed

165.

Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117PubMed

166.

Porter HJ, Quantrill AM, Fleming KA (1998) B19 parvovirus infection of myocardial cells. Lancet 1:535–536

167.

Pankuweit S, Moll R, Baantrup U, Portig I, Hufnagel G, Maisch B (2003) Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34:497–500PubMed

168.

Klein RM, Jiang H, Niederacher D, Adams O, Du M, Horlitz M, Schley P, Marx R, Lankisch MR, Brehm MU, Strauer BE, Gabbert HE, Scheffold T, Gülker H (2004) Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol 93(4):300–309PubMed

169.

Kühl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R (2003) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108(8):945–950PubMed

170.

Bültmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92–95PubMed

171.

Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S (2009) Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49:1660–1666PubMed

172.

Lotze U, Egerer R, Glück B, Zell R, Sigusch H, Erhardt C, Heim A, Kandolf R, Bock T, Wutzler P, Figulla HR (2010) Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. J Med Virol 82:1449–1457PubMed

173.

Corcioli F, Zakrzewska K, Rinieri A, Fanci R, Innocenti M, Civinini R, De Giorgi V, Di Lollo S, Azzi A (2008) Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 80:2005–2011PubMed

174.

Schenk T, Enders M, Pollak S, Hahn R, Huzly D (2009) High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47:106–110PubMed

175.

Stewart GC, Lopez-Molina J, Gottumukkala RV, Rosner GF, Anello MS, Hecht JL, Winters GL, Padera RF, Baughman KL, Lipes MA (2011) Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail 4(1):71–78PubMed

176.

Schmidt-Lucke C, Spillmann F, Bock T, Kühl U, Van Linthout S, Schultheiss HP, Tschöpe C (2010) Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. J Infect Dis 201:936–945PubMed

177.

Zafrir B, Aviv A, Reichman N, Flatau E (2005) Epstein-Barr virus associated pericarditis and pericardial effusion: case report and diagnostic aspects. Eur J Intern Med 16:528–530PubMed

178.

Roubille F, Gahide G, Moore-Morris T, Granier M, Davy JM, Vernhet H, Piot C (2008) Epstein Barr virus (EBV) and acute myopericarditis in an immunocompetent patient: first demonstrated case and discussion. Intern Med 47(7):627–629PubMed

179.

Chang YL, Parker ME, Nuovo G, Miller JB (2009) Human herpesvirus 6–related fulminant myocarditis and hepatitis in an immunocompetent adult with fatal outcome. Hum Pathol 40(5):740–745PubMed

180.

Leveque N, Boulagnon C, Brasselet C, Lesaffre F, Boutolleau D, Metz D, Fornes P, Andreoletti L (2011) A fatal case of Human Herpesvirus 6 chronic myocarditis in an immunocompetent adult. J Clin Virol 52(2):142–145PubMed

181.

Liao YC, Hsieh YC, Chang WC, Huang JL, Ting CT, Wu TJ (2011) Fulminant myocarditis in an adult with 2009 pandemic influenza A (H1N1 influenza) infection. J Chin Med Assoc 74(3):130–133PubMed

182.

Moulik M, Breinholt JP, Dreyer WJ, Kearney DL, Price JF, Clunie SK, Moffett BS, Kim JJ, Rossano JW, Jefferies JL, Bowles KR, O’Brian Smith E, Bowles NE, Denfield SW, Towbin JA (2010) Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol 56(7):582–592PubMed

183.

Shaw T, Elliot P, McKenna WJ (2002) Dilated cardiomyopathy: a genetical heterogeneous disease. Lancet 360:654–655PubMed

184.

Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60:5–10PubMed

185.

Maekawa Y, Ouzounian M, Opavsky MA, Liu PP (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115(1):5–8PubMed

186.

Linde A, Mosier D, Blecha F, Melgarejo T (2007) Innate immunity and inflammation–new frontiers in comparative cardiovascular pathology. Cardiovasc Res 73(1):26–36PubMed

187.

Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE (2010) A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285:23208–23223PubMed

188.

Mann DL (2011) The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 108(9):1133–1145PubMed

189.

Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP (2005) Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3 induced myocarditis, and influences type I interferon production. Circulation 112:2276–2285PubMed

190.

Mann DL, Topkara VK, Evans S, Barger PM (2010) Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc 121:34–50PubMed

191.

Schultheiss HP, Kühl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32:2616–2625PubMed

Title: Viral myocarditis: from experimental models to molecular diagnosis in patients
Authors: Sabine Pankuweit
Karin Klingel
Publication date: 01-11-2013
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 6/2013
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-012-9357-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Viral myocarditis: from experimental models to molecular diagnosis in patients

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2013

Foreword to special issue on “Myocarditis”

Idiopathic giant cell myocarditis and cardiac sarcoidosis

The immunological axis in heart failure: importance of the leukocyte differential

Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management

Dilated cardiomyopathy update: infectious-immune theory revisited

Anticoagulation in heart failure: current status and future direction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page